Other studies evaluating BRCA1 haplotypes have used a combination of the SNPs used in our study to evaluate risk in sporadic breast cancer [22] and interactions with hormonal therapy [21], but we are the first to have used the 3-SNP haplotype found to be associated with low MBPC in our population. This evidence concerns the gene BRCA1 and breast cancer.